Drugs / Loestrin 1.5/30
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02480881 | Jul 2015 → Jan 2016 | HIV infectious disease | ViiV Healthcare | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Loestrin 1.5/30 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02480881 ↗ |
| Route | Oral | “Treatment C/Cycle 3: Loestrin 1.5/30 taken by mouth.” NCT02480881 ↗ |